United Kingdom· GB-APID-18765811000001108
Xiapex 0.9mg powder and solvent for solution for injection vials
A collagenase clostridium histolyticum product containing collagenase clostridium histolyticum, registered in United Kingdom by Swedish Orphan Biovitrum Ltd. The same ATC class is registered in 5 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Collagenase clostridium histolyticum is registered in 5 of 19 countries.
Countries holding a registration under ATC M09AB02 (collagenase clostridium histolyticum), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Collagenase clostridium histolyticum · ATC M09AB02
5 / 19 countries
- Belgiumprice
- Finlandprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Collagenase clostridium histolyticum
- Manufacturer
- Swedish Orphan Biovitrum Ltd
- Country
- United Kingdom (GB)
- ATC code
- M09AB02
- ATC class
- Collagenase clostridium histolyticum
- Defined daily dose
- 0.9 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5013457027648
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
54 interactions on record for collagenase clostridium histolyticum.
Graded by severity as the source publishes them — 54 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Collagenase clostridium histolyticum · interactions on record
54 records
- 54 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Collagenase clostridium histolyticum in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/88d8d2e1-05d3-4e44-92dd-7e7ada87cdfe GET /v1/drugs/88d8d2e1-05d3-4e44-92dd-7e7ada87cdfe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "18765811000001108",
"desc": "Xiapex 0.9mg powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "18765711000001100",
"source": "dmd",
"vtm_id": "786713000",
"strength": "900 microgram",
"substance": "Collagenase clostridium histolyticum",
"ingredient": "Collagenase clostridium histolyticum",
"supplier_code": "4232111000001108"
}See everything about collagenase clostridium histolyticum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.